FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/5/2026
Roth Capital analyst David Bain raised the price target on USANA Health Sciences Inc. (NYSE: USNA) to $126.00 (from $107.00) while maintaining a Buy rating.
The analyst comments "Following a 7%/~24% revenue/EBITDA beat versus consensus, we raise our CY21/CY22 estimates and target price.... More

